NCT00051168View on ClinicalTrials.gov

A Long-term Safety Study of Once-daily Travatan

PHASE3CompletedINTERVENTIONAL

Enrollment

502

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2009

Conditions

Glaucoma, Open-angleOcular Hypertension

Interventions

DRUG

Travatan

Travoprost (0.004%) 1 drop each eye once daily

Trial Locations (1)

Unknown

Europe, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY